Epidox 10mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Epirubicin (10mg)
Overview Epidox 10mg Injection
Docefrin 10mg Injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is vital; incorrect usage or overdose can lead to severe adverse effects. Benefits may not be apparent for weeks or months; discontinue only under medical supervision. This medication reduces contraceptive efficacy; reliable birth control is recommended for both men and women during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests are necessary to monitor blood cell counts, kidney, liver, and heart function. Prior to treatment, disclose any liver or heart conditions, and list all other medications, as interactions may compromise efficacy or alter its action. Inform your doctor of pregnancy or breastfeeding.
Uses of Epidox 10mg Injection
Malignancy
Major Benefits of Epidox 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epidox 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epidox 10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Epidox 10mg Injection works:
Epidox 10mg Injection is a chemotherapeutic agent used in breast cancer treatment. Its mechanism of action involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within breast cancer cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, thereby impeding tumor growth and ultimately inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Epidox 10mg Injection should not be taken with alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Epidox 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Epidox 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Epidox 10mg Injection may result in adverse reactions that could compromise driving ability. These reactions may include nausea and vomiting, potentially causing temporary driving impairment.
KidneySAFE IF PRESCRIBED
The use of Epidox 10mg Injection in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, medical advice is essential. For patients exhibiting serum creatinine levels exceeding 5 mg/dL, reduced dosages should be explored in consultation with a physician.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Epidox 10mg Injection, as dose modification may be necessary. Consult a physician for guidance. Epidox 10mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Epidox 10mg Injection :
NA
Facts to Know About Epidox 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Active Class | Cytotoxic alkaloids |
3,018 People bought this recently